Co-Diagnostics SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCo-Diagnostics announces 1-for-25 reverse stock split effective November 24, 2026, to support Nasdaq $1.00 minimum bid compliance
Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Financial statements and exhibits
AI summary, unreviewedCo-Diagnostics Shareholders Approve Plan Share Increase, Reverse Split Authority of Up to 1-for-750 and Warrant Issuance at Special Meeting
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCo-Diagnostics Q3 2026 Net Loss Narrows to $1.01 Per Share vs $1.25 Consensus; Revenue Rises to $0.3 Million, Cash Falls to $0.7 Million
Submission of matters to a vote of security holders
Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits
Submission of matters to a vote of security holders
AI summary, unreviewedCo-Diagnostics Annual Meeting Fails Quorum Again, Adjourned to October 14, 2026
Submission of matters to a vote of security holders
Regulation FD disclosure · Financial statements and exhibits
Other events · Financial statements and exhibits
Other events
Departure/appointment of directors or officers
Submission of matters to a vote of security holders
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits
Entry into a material definitive agreement · Financial statements and exhibits